Use of the neurotoxic agents kainic acid and tetanus toxin in the extrapyramidal system.
D000818:Animals; D001921:Brain / Q000502:physiology; D002531:Cerebellum / Q000502:physiology; D005116:Extrapyramidal Tracts / Q000187:drug effects / Q000502:physiology*; D006624:Hippocampus / Q000502:physiology; D006816:Huntington Disease / Q000139:chemically induced; D006892:Hydroxydopamines / Q000494:pharmacology; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology; D007608:Kainic Acid / Q000494:pharmacology*; D009498:Neurotoxins / Q000494:pharmacology*; D011759:Pyrrolidines / Q000494:pharmacology*; D051381:Rats; D012160:Retina / Q000502:physiology; D013744:Tetanus Toxin / Q000494:pharmacology*; D005680:gamma-Aminobutyric Acid / Q000502:physiology
D006892:Hydroxydopamines; D009498:Neurotoxins; D011759:Pyrrolidines; D013744:Tetanus Toxin; D005680:gamma-Aminobutyric Acid; D007608:Kainic Acid